Resistance to Marek's disease herpesvirus-induced lymphoma is multiphasic and dependent on host genotype.
Genotype-dependent differences in Marek's disease (MD) susceptibility were identified using 14-day-old line N and 6(1) (resistant) and 151 and 7(2) (susceptible) inbred chickens infected with HPRS-16 MD virus (MDV). All line 72 chickens developed progressive MD. Line 15I had fluctuating MD-specific clinical signs and individuals recovered. A novel histologic scoring system enabled indices to be calculated for lymphocyte infiltration into nonlymphoid organs. All genotypes had increased mean lesion scores (MLSs) and mean total lesion scores after MDV infection. These differed quantitatively and qualitatively between the genotypes. Lines 6(1) and 7(2) had a similar MLS distribution in the cytolytic phase, although scores were greater in line 7(2). At the time lymphomas were visible in line 7(2), histologic lesions in line 6(1) were regressing. AV37+ cells were present in similar numbers in all genotypes in the cytolytic phase, suggesting that neoplastically transformed cells were present in all genotypes regardless of MD susceptibility. After the cytolytic phase, AV37+ cell numbers increased in lines 7(2) and 15I but decreased in lines 6(1) and N. In the cytolytic and latent phases, in all genotypes, most infiltrating cells were CD4+. After this time, line 7(2) and 15I lesions increased in size and most cells were CD4+; line 6(1) and N lesions decreased in size and most cells were CD8+. In all genotypes, AV37 immunostaining was weak in lesions with many CD8+ cells, suggesting that AV37 antigen expression or AV37+ cells were controlled by CD8+ cells. The rank order, determined by clinical signs and pathology, for MD susceptibility (highest to lowest) was 7(2) > 15I > 6(1) > N.
Burgess
S C
SC
Division of Immunopathology, Institute for Animal Health, Compton, Newbury, Berks, UK. shane.burgess@bbsrc.ac.uk
Basaran
B H
BH
Davison
T F
TF
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D002472:Cell Transformation, Viral / Q000235:genetics / Q000276:immunology; D002645:Chickens / Q000235:genetics*; D004279:DNA, Viral / Q000737:chemistry; D020022:Genetic Predisposition to Disease; D006066:Gonads / Q000473:pathology; D008381:Herpesvirus 2, Gallid / Q000472:pathogenicity*; D007150:Immunohistochemistry / Q000662:veterinary; D008099:Liver / Q000473:pathology; D008223:Lymphoma / Q000235:genetics* / Q000276:immunology / Q000473:pathology / Q000821:virology*; D008380:Marek Disease / Q000150:complications / Q000235:genetics* / Q000473:pathology; D016133:Polymerase Chain Reaction / Q000662:veterinary; D011201:Poultry Diseases / Q000235:genetics* / Q000473:pathology / Q000821:virology; D011531:Proventriculus / Q000473:pathology; D020426:Sciatic Neuropathy / Q000473:pathology / Q000662:veterinary; D012867:Skin / Q000473:pathology; D013047:Specific Pathogen-Free Organisms
D000911:Antibodies, Monoclonal; D004279:DNA, Viral